Three more pharma megamergers to go?

NYSE:SNY) and Novartis, but we should not rule out (NYSE: JNJ) or GlaxoSmithKline, if its acquisition of Allergan Inc. (NYSE:AGN) does not come to fruition.' In March, Glaxo was rumored to be planning a takeover of cosmetic drug developer Allergan. We've...